Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

Blood

Volumn 122, Issue 19, 2013, Pages 3298-3307

  Migliorini, Gabriele ^a   Fiege, Bettina ^b   Hosking, Fay J ^a   Ma, Yussanne ^a   Kumar, Rajiv ^b   Sherborne, Amy L ^a   Da Silva Filho, Miguel Inacio ^b   Vijayakrishnan, Jayaram ^a   Koehler, Rolf ^c   Thomsen, Hauke ^b   Irving, Julie A ^d   Allan, James M ^d   Lightfoot, Tracy ^e   Roman, Eve ^e   Kinsey, Sally E ^f,g   Sheridan, Eamonn ^g   Thompson, Pamela ^h   Hoffmann, Per ⁱ   Nöthen, Markus M ^i,j   Mühleisen, Thomas W ⁱ   Eisele, Lewin ^k   Zimmermann, Martin ^l   Bartram, Claus R ^c   Schrappe, Martin ^m   Greaves, Mel ^a   Stanulla, Martin ^l   Hemminki, Kari ^b,n   Houlston, Richard S ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF YORK   (United Kingdom)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ UNIVERSITY OF BONN   (Germany)

^j GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^k UNIVERSITY HOSPITAL ESSEN   (Germany)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁿ LUND UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CCAAT ENHANCER BINDING PROTEIN EPSILON; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; TRANSCRIPTION FACTOR GATA 3; VINCRISTINE; GATA3 PROTEIN, HUMAN; PHOSPHOTRANSFERASE; PIP4K2A PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; B CELL LEUKEMIA; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RISK; CASE CONTROL STUDY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; AGE; B LYMPHOCYTE; CHROMOSOME 10; EXON; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; INTRON; META ANALYSIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL;

AGE FACTORS; ALLELES; B-LYMPHOCYTES; CHILD; CHROMOSOMES, HUMAN, PAIR 10; EXONS; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRONS; MALE; MIDDLE AGED; PHENOTYPE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVAL ANALYSIS;

EID: 84891671233     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-491316     Document Type: Article

References (37)

1. Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull. 1996;52(4):682-703.
2. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203.
3. Crouch S, Lightfoot T, Simpson J, Smith A, Ansell P, Roman E. Infectious illness in children subsequently diagnosed with acute lymphoblastic leukemia: modeling the trends from birth to diagnosis. Am J Epidemiol. 2012;176(5):402-408.
4. Kharazmi E, da Silva Filho MI, Pukkala E, Sundquist K, Thomsen H, Hemminki K. Familial risks for childhood acute lymphocytic leukaemia in Sweden and Finland: far exceeding the effects of known germline variants. Br J Haematol. 2012; 159(5):585-588.
5. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9): 1006-1010.
6. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42(6):492-494.
7. Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010; 115(16):3206-3214.
8. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
9. Clayton DG, Walker NM, Smyth DJ, et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet. 2005;37(11):1243-1246.
10. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8): 904-909.
11. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-1558.
12. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4(1):87-90.
13. Wray NR, Yang J, Goddard ME, Visscher PM. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 2010; 6(2):e1000864.
14. Myers S, Bottolo L, Freeman C, McVean G, Donnelly P. A fine-scale map of recombination rates and hotspots across the human genome. Science. 2005;310(5746):321-324.
15. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576): 2225-2229.
16. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A; NISC Comparative Sequencing Program. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15(7):901-913.
17. Siepel A, Bejerano G, Pedersen JS, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15(8):1034-1050.
18. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol. 2010;28(8): 817-825.
19. Kalbfleisch J, Prentice R. The statistical analysis of failure time data, 2nd ed. Hoboken, New Jersey: John Wiley and Sons; 2002.
20. Machin D, Cheung Y, Parmar M. Survival analysis - a practical approach, 2nd ed. Chichester, West Sussex: John Wiley and Sons Ltd; 2006.
21. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science. 2009;325(5945):1246-1250.
22. Nica AC, Parts L, Glass D, et al; MuTHER Consortium. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 2011;7(2): e1002003.
23. Stranger BE, Montgomery SB, Dimas AS, et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 2012;8(4): e1002639.
24. Chang JS, Wiemels JL, Chokkalingam AP, et al. Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2152-2163.
25. Swerdlow A. Dos Santos Silva I, Doll R. Cancer incidence and mortality in England and Wales. Oxford, United Kingdom: Oxford University Press; 2001.
26. Xu H, Yang W, Perez-Andreu V, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst. 2013;105(10):733-742.
27. Walsh KM, de Smith AJ, Chokkalingam AP, et al. Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. Blood. 2013;121(23): 4808-4809.
28. Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165-1174.
29. Bakker SC, Hoogendoorn ML, Hendriks J, et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav. 2007;6(2): 113-119.
30. Schwab SG, Knapp M, Sklar P, et al. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol Psychiatry. 2006;11(9):837-846.
31. Klein Wolterink RG, Serafini N, van Nimwegen M, et al. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-51 and IL-131 type 2 innate lymphoid cells. Proc Natl Acad Sci USA. 2013;110(25): 10240-10245.
32. Banerjee A, Northrup D, Boukarabila H, Jacobsen SE, Allman D. Transcriptional repression of Gata3 is essential for early B cell commitment. Immunity. 2013;38(5):930-942.
33. Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012; 481(7380):157-163.
34. Enciso-Mora V, Broderick P, Ma Y, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet. 2010;42(12):1126-1130.
35. Dong J, Hu Z, Wu C, et al. Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet. 2012;44(8): 895-899.
36. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.
37. Usary J, Llaca V, Karaca G, et al. Mutation of GATA3 in human breast tumors. Oncogene. 2004;23(46):7669-7678.